Summary
The National Institutes of Health (NIH) is forecasting a funding opportunity focused on Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe). This opportunity targets research and development in the area of extracellular vesicle (EV)-based therapeutics applied to regenerative medicine. The opportunity is currently in a forecasted status, meaning full details, scope, and award parameters have not yet been published. No additional programmatic or budgetary details are available in the current notice.
